These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30556647)

  • 1. Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation.
    Shou X; Li Y; Hu W; Ye T; Wang G; Xu F; Sui M; Xu Y
    Mol Oncol; 2019 Apr; 13(4):781-791. PubMed ID: 30556647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
    Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
    Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
    J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
    Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
    Musella V; Pietrantonio F; Di Buduo E; Iacovelli R; Martinetti A; Sottotetti E; Bossi I; Maggi C; Di Bartolomeo M; de Braud F; Daidone MG; Cappelletti V
    Int J Cancer; 2015 Sep; 137(6):1467-74. PubMed ID: 25704501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
    Raeisossadati R; Farshchian M; Ganji A; Tavassoli A; Velayati A; Dadkhah E; Chavoshi S; Mehrabi Bahar M; Memar B; Rajabi Mashhadi MT; Naseh H; Forghanifard MM; Moghbeli M; Moaven O; Abbaszadegan MR
    Int J Colorectal Dis; 2011 Oct; 26(10):1265-70. PubMed ID: 21573768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
    Tan Y; Wu H
    Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
    Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.
    de Albuquerque A; Kubisch I; Stölzel U; Ernst D; Boese-Landgraf J; Breier G; Stamminger G; Fersis N; Kaul S
    J Transl Med; 2012 Nov; 10():222. PubMed ID: 23146106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
    Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
    Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.